SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $928,174,362 |
| Positions | 156 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| SPDR SERIES TRUST | XBI | ST STR SP BIOT | $47,475,000 | 300,000 |
| ABIVAX SA | ABVX | SPONSORED ADS | $45,454,986 | 341,100 |
| ABIVAX SA | ABVX | SPONSORED ADS | $43,352,978 | 328,635 |
| KODIAK SCIENCES INC | KOD | COM | $41,287,080 | 1,059,730 |
| ABIVAX SA | ABVX | SPONSORED ADS | $33,315,000 | 250,000 |
| IONIS PHARMACEUTICALS INC | IONS | COM | $31,716,000 | 400,000 |
| MODERNA INC | MRNA | COM | $28,012,000 | 400,000 |
| ALUMIS INC | ALMS | COM | $24,497,220 | 870,548 |
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $24,386,773 | 72,842 |
| IONIS PHARMACEUTICALS INC | IONS | COM | $23,787,000 | 300,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.